World Heart Corporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for World Heart Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

World Heart Corporation. The Group's principal activity is to develop artificial heart technologies. The Group is focused on two technologies: Novacor LVAS and the HeartSaver Ventricular Assist Device (HeartSaver). Novacor technology is currently in commercial production and the HeartSaver technology is currently under development. This technology is being developed from licensed artificial heart and related technologies developed by the Cardiovascular Devices Division (CVD) of the Ottawa Heart Institute Research Corporation. The Group operates in Canada and the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report